Electrooculography After Photodynamic Therapy-Reference-Cited by-同舟云学术

Electrooculography After Photodynamic Therapy

Published:2005-09 Issue:2 Volume:111 Page:83-86
ISSN:0012-4486
Container-title:Documenta Ophthalmologica
language:en
Short-container-title:Doc Ophthalmol

Author:

Oner Ayse,Karakucuk Sarper,Mirza Ertugrul,Erkilic Kuddusi

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s10633-005-4410-4.pdf

Reference15 articles.

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in agerelated macular degeneration with verteporfin. One-year results of 2 randomized clinical trials: TAP report 1. Arch Ophthalmol 1999; 117: 1329–45

2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in agerelated macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials: TAP report 2. Arch Ophthalmol 2001; 119: 198–207

3. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001; 131: 541–60

4. Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular Degeneration

5. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy;Clinical Ophthalmology;2012-10

2. Evaluation of verteporfin pharmakokinetics – redefining the need of photosensitizers in ophthalmology;Expert Opinion on Drug Metabolism & Toxicology;2012-07-05

3. A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy;Turkish Journal of Medical Sciences;2012-01-01

4. COMPARISON OF EFFICACY AND SAFETY BETWEEN HALF-FLUENCE AND FULL-FLUENCE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY;Retina;2011-01

5. FLUORESCEIN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY;Retina;2010-11